01 1Juzen Chemical Corporation
02 1Korea Biochem Pharmaceutical Co., Ltd.
01 1Astellas Pharma Korea Co., Ltd.
02 1Korea Biochem Pharmaceutical Co., Ltd.
01 2Ipragliflozin L-proline
01 1Japan
02 1South Korea
Registrant Name : Astellas Pharma Korea Co., Ltd.
Registration Date : 2014-09-05
Registration Number : No. 3778-5-ND
Manufacturer Name : Juzen Chemical Corporation
Manufacturer Address : 1-10, Kiba-machi, Toyama City, Toyama 930-0806
Registrant Name : Korea Biochem Pharmaceutical Co., Ltd.
Registration Date : 2022-12-14
Registration Number : 2152-19-ND
Manufacturer Name : Korea Biochem Pharmaceutical...
Manufacturer Address : 204 Sandan-gil, Jeonui-myeon, Sejong Special Self-Governing City
A Ipragliflozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ipragliflozin, including repackagers and relabelers. The FDA regulates Ipragliflozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ipragliflozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ipragliflozin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ipragliflozin supplier is an individual or a company that provides Ipragliflozin active pharmaceutical ingredient (API) or Ipragliflozin finished formulations upon request. The Ipragliflozin suppliers may include Ipragliflozin API manufacturers, exporters, distributors and traders.
click here to find a list of Ipragliflozin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ipragliflozin Drug Master File in Korea (Ipragliflozin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ipragliflozin. The MFDS reviews the Ipragliflozin KDMF as part of the drug registration process and uses the information provided in the Ipragliflozin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ipragliflozin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ipragliflozin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ipragliflozin suppliers with KDMF on PharmaCompass.
We have 2 companies offering Ipragliflozin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?